chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Sinus congestion, Upper-airway cough syndrome
Clinical narrative: NASAL DRIP; MILD CONGESTION; INTENSE BODY ACHES; WEAKNESS BEHIND KNEES WORST ON LEFT SIDE; CHILLS; MEDIUM GRADE HEADACHE; FATIGUE; LOW GRADE FEVER; MUSCLE ACHE; NUMBNESS IN BOTH FEET - FRONTAL FROM BUNION OUTWARD MAINLY ON BOTTOM; This spontaneous report received from a patient concerned a 58 year old male. The patient's weight was 150 pounds, and height was 180 centimeters. The patient's concurrent conditions included alcohol use, and nonsmoker, and other pre-existing medical conditions included the patient had no allergy to vaccine, drug, or food and no history of drug abuse. the patient had no illness at the time of vaccination, no past history of similar event, no adverse event after any previous vaccination, no family history of any disease or allergy relevant to vaccination and hospitalization in last 30 days. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 on right arm muscle for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced numbness in both feet - frontal from bunion outward mainly on bottom. On 31-MAR-2021, the subject experienced intense body aches. On 31-MAR-2021, the subject experienced weakness behind knees worst on left side. On 31-MAR-2021, the subject experienced chills. On 31-MAR-2021, the subject experienced medium grade headache. On 31-MAR-2021, the subject experienced fatigue. On 31-MAR-2021, the subject experienced low grade fever. On 31-MAR-2021, the subject experienced muscle ache. On 01-APR-2021, the subject experienced nasal drip. On 01-APR-2021, the subject experienced mild congestion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 02-APR-2021, was recovering from medium grade headache, intense body aches, nasal drip, mild congestion, low grade fever, and muscle ache, had not recovered from numbness in both feet - frontal from bunion outward mainly on bottom, and weakness behind knees worst on left side, and the outcome of fatigue was not reported. This report was non-serious.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Hypoaesthesia, Muscular weakness
Clinical narrative: NASAL DRIP; MILD CONGESTION; INTENSE BODY ACHES; WEAKNESS BEHIND KNEES WORST ON LEFT SIDE; CHILLS; MEDIUM GRADE HEADACHE; FATIGUE; LOW GRADE FEVER; MUSCLE ACHE; NUMBNESS IN BOTH FEET - FRONTAL FROM BUNION OUTWARD MAINLY ON BOTTOM; This spontaneous report received from a patient concerned a 58 year old male. The patient's weight was 150 pounds, and height was 180 centimeters. The patient's concurrent conditions included alcohol use, and nonsmoker, and other pre-existing medical conditions included the patient had no allergy to vaccine, drug, or food and no history of drug abuse. the patient had no illness at the time of vaccination, no past history of similar event, no adverse event after any previous vaccination, no family history of any disease or allergy relevant to vaccination and hospitalization in last 30 days. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 on right arm muscle for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced numbness in both feet - frontal from bunion outward mainly on bottom. On 31-MAR-2021, the subject experienced intense body aches. On 31-MAR-2021, the subject experienced weakness behind knees worst on left side. On 31-MAR-2021, the subject experienced chills. On 31-MAR-2021, the subject experienced medium grade headache. On 31-MAR-2021, the subject experienced fatigue. On 31-MAR-2021, the subject experienced low grade fever. On 31-MAR-2021, the subject experienced muscle ache. On 01-APR-2021, the subject experienced nasal drip. On 01-APR-2021, the subject experienced mild congestion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 02-APR-2021, was recovering from medium grade headache, intense body aches, nasal drip, mild congestion, low grade fever, and muscle ache, had not recovered from numbness in both feet - frontal from bunion outward mainly on bottom, and weakness behind knees worst on left side, and the outcome of fatigue was not reported. This report was non-serious.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nasal congestion, Pain, Pyrexia, Upper-airway cough syndrome
Clinical narrative: NASAL DRIP; MILD CONGESTION; INTENSE BODY ACHES; WEAKNESS BEHIND KNEES WORST ON LEFT SIDE; CHILLS; MEDIUM GRADE HEADACHE; FATIGUE; LOW GRADE FEVER; MUSCLE ACHE; NUMBNESS IN BOTH FEET - FRONTAL FROM BUNION OUTWARD MAINLY ON BOTTOM; This spontaneous report received from a patient concerned a 58 year old male. The patient's weight was 150 pounds, and height was 180 centimeters. The patient's concurrent conditions included alcohol use, and nonsmoker, and other pre-existing medical conditions included the patient had no allergy to vaccine, drug, or food and no history of drug abuse. the patient had no illness at the time of vaccination, no past history of similar event, no adverse event after any previous vaccination, no family history of any disease or allergy relevant to vaccination and hospitalization in last 30 days. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 on right arm muscle for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced numbness in both feet - frontal from bunion outward mainly on bottom. On 31-MAR-2021, the subject experienced intense body aches. On 31-MAR-2021, the subject experienced weakness behind knees worst on left side. On 31-MAR-2021, the subject experienced chills. On 31-MAR-2021, the subject experienced medium grade headache. On 31-MAR-2021, the subject experienced fatigue. On 31-MAR-2021, the subject experienced low grade fever. On 31-MAR-2021, the subject experienced muscle ache. On 01-APR-2021, the subject experienced nasal drip. On 01-APR-2021, the subject experienced mild congestion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 02-APR-2021, was recovering from medium grade headache, intense body aches, nasal drip, mild congestion, low grade fever, and muscle ache, had not recovered from numbness in both feet - frontal from bunion outward mainly on bottom, and weakness behind knees worst on left side, and the outcome of fatigue was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bedridden, Pain, Thrombosis
Clinical narrative: blood clots in his lungs; Lot of pain in his left side; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 06Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 for COVID-19 immunisation and had lot of pain in his left side (1 st dose-During period (first part of Jan and part of Feb) he was bedridden). It was reported that caller received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 16Jan2021, in the hospital. On 06Feb2021 he received the second dose of the vaccine. Twelve days later he was diagnosed with multiple blood clots in his lungs, from Feb2021 he was hospitalized, he was prescribed to take Eliquis (Apixaban; blood thinner) 5mg tablets for 6 months. During that period (first part of Jan and part of Feb) he was bedridden because he had a lot of pain in his left side and it would not let him get out of bed, so he was on bed for a while. His primary care doctor told him that the clots might have appeared in his leg and went to his lung. Caller would like to know if any participant developed blood clots during the clinical trials of the vaccine. Therapeutic measures were taken as a result of blood clots in his lungs. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, Thrombosis
Clinical narrative: blood clots in his lungs; Lot of pain in his left side; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 06Feb2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 for COVID-19 immunisation and had lot of pain in his left side (1 st dose-During period (first part of Jan and part of Feb) he was bedridden). It was reported that caller received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 16Jan2021, in the hospital. On 06Feb2021 he received the second dose of the vaccine. Twelve days later he was diagnosed with multiple blood clots in his lungs, from Feb2021 he was hospitalized, he was prescribed to take Eliquis (Apixaban; blood thinner) 5mg tablets for 6 months. During that period (first part of Jan and part of Feb) he was bedridden because he had a lot of pain in his left side and it would not let him get out of bed, so he was on bed for a while. His primary care doctor told him that the clots might have appeared in his leg and went to his lung. Caller would like to know if any participant developed blood clots during the clinical trials of the vaccine. Therapeutic measures were taken as a result of blood clots in his lungs. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Full blood count, Metabolic function test, Pyrexia, Tachycardia
Clinical narrative: ELEVATED HEART RATE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A and expiry: 21-JUN-2021) dose was not reported, administered on 31-MAR-2021 17:00 to the right arm for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced elevated heart rate. Laboratory data included: Heart rate (NR: not provided) 112 to 135 /min. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of elevated heart rate was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard  procedure as the case assessed as non-serious
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: ELEVATED HEART RATE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A and expiry: 21-JUN-2021) dose was not reported, administered on 31-MAR-2021 17:00 to the right arm for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced elevated heart rate. Laboratory data included: Heart rate (NR: not provided) 112 to 135 /min. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of elevated heart rate was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard  procedure as the case assessed as non-serious
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Injection site paraesthesia, Neck pain, Nodule, Pain in extremity
Clinical narrative: TINGLING OF THE ARMS; RIGHT NECK STIFFNESS; HEADACHE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and  expiry: UNKNOWN) once total dose was not reported, administered on 01-APR-2021 13:30 to right arm for prophylactic vaccination. Concomitant medications included ibuprofen for drug used for unknown indication. On 01-APR-2021, the subject experienced tingling of the arms. On 01-APR-2021, the subject experienced right neck stiffness.  On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tingling of the arms, right neck stiffness and headache was not reported. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tenderness
Clinical narrative: TINGLING OF THE ARMS; RIGHT NECK STIFFNESS; HEADACHE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and  expiry: UNKNOWN) once total dose was not reported, administered on 01-APR-2021 13:30 to right arm for prophylactic vaccination. Concomitant medications included ibuprofen for drug used for unknown indication. On 01-APR-2021, the subject experienced tingling of the arms. On 01-APR-2021, the subject experienced right neck stiffness.  On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tingling of the arms, right neck stiffness and headache was not reported. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Musculoskeletal stiffness, Paraesthesia
Clinical narrative: TINGLING OF THE ARMS; RIGHT NECK STIFFNESS; HEADACHE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and  expiry: UNKNOWN) once total dose was not reported, administered on 01-APR-2021 13:30 to right arm for prophylactic vaccination. Concomitant medications included ibuprofen for drug used for unknown indication. On 01-APR-2021, the subject experienced tingling of the arms. On 01-APR-2021, the subject experienced right neck stiffness.  On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tingling of the arms, right neck stiffness and headache was not reported. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Application site nodule, Headache, Injection site pain, Injection site paraesthesia, Musculoskeletal stiffness
Clinical narrative: TINGLING OF THE ARMS; RIGHT NECK STIFFNESS; HEADACHE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and  expiry: UNKNOWN) once total dose was not reported, administered on 01-APR-2021 13:30 to right arm for prophylactic vaccination. Concomitant medications included ibuprofen for drug used for unknown indication. On 01-APR-2021, the subject experienced tingling of the arms. On 01-APR-2021, the subject experienced right neck stiffness.  On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tingling of the arms, right neck stiffness and headache was not reported. This report was non-serious.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain
Clinical narrative: TINGLING OF THE ARMS; RIGHT NECK STIFFNESS; HEADACHE; This spontaneous report received from a patient concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and  expiry: UNKNOWN) once total dose was not reported, administered on 01-APR-2021 13:30 to right arm for prophylactic vaccination. Concomitant medications included ibuprofen for drug used for unknown indication. On 01-APR-2021, the subject experienced tingling of the arms. On 01-APR-2021, the subject experienced right neck stiffness.  On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tingling of the arms, right neck stiffness and headache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Injection site paraesthesia, Neck pain, Nodule, Pain in extremity
Clinical narrative: TINGLING IN ARM; STIFF NECK; PAIN IN NECK; SMALL KNOT SORE TO THE TOUCH AND ABOUT THE SIZE OF A PEA; PAIN AT INJECTION SITE; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced stiff neck. On 01-APR-2021, the subject experienced pain in neck. On 01-APR-2021, the subject experienced small knot sore to the touch and about the size of a pea. On 01-APR-2021, the subject experienced pain at injection site. On 01-APR-2021, the subject experienced mild headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tingling in arm, stiff neck, pain in neck, small knot sore to the touch and about the size of a pea, pain at injection site, and mild headache. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tenderness
Clinical narrative: TINGLING IN ARM; STIFF NECK; PAIN IN NECK; SMALL KNOT SORE TO THE TOUCH AND ABOUT THE SIZE OF A PEA; PAIN AT INJECTION SITE; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced stiff neck. On 01-APR-2021, the subject experienced pain in neck. On 01-APR-2021, the subject experienced small knot sore to the touch and about the size of a pea. On 01-APR-2021, the subject experienced pain at injection site. On 01-APR-2021, the subject experienced mild headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tingling in arm, stiff neck, pain in neck, small knot sore to the touch and about the size of a pea, pain at injection site, and mild headache. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Musculoskeletal stiffness, Paraesthesia
Clinical narrative: TINGLING IN ARM; STIFF NECK; PAIN IN NECK; SMALL KNOT SORE TO THE TOUCH AND ABOUT THE SIZE OF A PEA; PAIN AT INJECTION SITE; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced stiff neck. On 01-APR-2021, the subject experienced pain in neck. On 01-APR-2021, the subject experienced small knot sore to the touch and about the size of a pea. On 01-APR-2021, the subject experienced pain at injection site. On 01-APR-2021, the subject experienced mild headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tingling in arm, stiff neck, pain in neck, small knot sore to the touch and about the size of a pea, pain at injection site, and mild headache. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Application site nodule, Headache, Injection site pain, Injection site paraesthesia, Musculoskeletal stiffness
Clinical narrative: TINGLING IN ARM; STIFF NECK; PAIN IN NECK; SMALL KNOT SORE TO THE TOUCH AND ABOUT THE SIZE OF A PEA; PAIN AT INJECTION SITE; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced stiff neck. On 01-APR-2021, the subject experienced pain in neck. On 01-APR-2021, the subject experienced small knot sore to the touch and about the size of a pea. On 01-APR-2021, the subject experienced pain at injection site. On 01-APR-2021, the subject experienced mild headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tingling in arm, stiff neck, pain in neck, small knot sore to the touch and about the size of a pea, pain at injection site, and mild headache. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain
Clinical narrative: TINGLING IN ARM; STIFF NECK; PAIN IN NECK; SMALL KNOT SORE TO THE TOUCH AND ABOUT THE SIZE OF A PEA; PAIN AT INJECTION SITE; MILD HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced stiff neck. On 01-APR-2021, the subject experienced pain in neck. On 01-APR-2021, the subject experienced small knot sore to the touch and about the size of a pea. On 01-APR-2021, the subject experienced pain at injection site. On 01-APR-2021, the subject experienced mild headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tingling in arm, stiff neck, pain in neck, small knot sore to the touch and about the size of a pea, pain at injection site, and mild headache. This report was non-serious.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Cardiac disorder, Chest X-ray, Electrocardiogram, Migraine
Clinical narrative: ELEVATED BLOOD PRESSURE; CHEST PAIN; SHORTNESS OF BREATH; VOMITING; NAUSEA; HEADACHE MIGRAINE; This spontaneous report received from a consumer concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and tension headache, and other pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: 20-JUN-2021) dose was not reported, administered to left arm, on 02-APR-2021 13:40 for prophylactic vaccination. Concomitant medications included atenolol for high blood pressure. On 02-APR-2021, the subject experienced headache migraine. On 03-APR-2021, the subject experienced elevated blood pressure. On 03-APR-2021, the subject experienced chest pain. On 03-APR-2021, the subject experienced shortness of breath. On 03-APR-2021, the subject experienced vomiting. On 03-APR-2021, the subject experienced nausea. Laboratory data included: Blood pressure (NR: not provided) 180/110 mmHg, and EKG (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from elevated blood pressure, chest pain, shortness of breath, vomiting, headache migraine, and nausea on 03-APR-2021. This report was non-serious.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Chest pain, Dyspnoea, Electrocardiogram
Clinical narrative: ELEVATED BLOOD PRESSURE; CHEST PAIN; SHORTNESS OF BREATH; VOMITING; NAUSEA; HEADACHE MIGRAINE; This spontaneous report received from a consumer concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and tension headache, and other pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: 20-JUN-2021) dose was not reported, administered to left arm, on 02-APR-2021 13:40 for prophylactic vaccination. Concomitant medications included atenolol for high blood pressure. On 02-APR-2021, the subject experienced headache migraine. On 03-APR-2021, the subject experienced elevated blood pressure. On 03-APR-2021, the subject experienced chest pain. On 03-APR-2021, the subject experienced shortness of breath. On 03-APR-2021, the subject experienced vomiting. On 03-APR-2021, the subject experienced nausea. Laboratory data included: Blood pressure (NR: not provided) 180/110 mmHg, and EKG (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from elevated blood pressure, chest pain, shortness of breath, vomiting, headache migraine, and nausea on 03-APR-2021. This report was non-serious.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Migraine, Nausea, Vomiting
Clinical narrative: ELEVATED BLOOD PRESSURE; CHEST PAIN; SHORTNESS OF BREATH; VOMITING; NAUSEA; HEADACHE MIGRAINE; This spontaneous report received from a consumer concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and tension headache, and other pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: 20-JUN-2021) dose was not reported, administered to left arm, on 02-APR-2021 13:40 for prophylactic vaccination. Concomitant medications included atenolol for high blood pressure. On 02-APR-2021, the subject experienced headache migraine. On 03-APR-2021, the subject experienced elevated blood pressure. On 03-APR-2021, the subject experienced chest pain. On 03-APR-2021, the subject experienced shortness of breath. On 03-APR-2021, the subject experienced vomiting. On 03-APR-2021, the subject experienced nausea. Laboratory data included: Blood pressure (NR: not provided) 180/110 mmHg, and EKG (NR: not provided) unknown. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from elevated blood pressure, chest pain, shortness of breath, vomiting, headache migraine, and nausea on 03-APR-2021. This report was non-serious.
Age: 46.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Asthenopia, Blood pressure increased, Blood pressure measurement, Blood urine present
Clinical narrative: URINARY TRACT INFECTION; BLOOD PRESSURE SO HIGH FELT LIKE BODY WAS GOING TO EXPLODE; This spontaneous report received from a patient concerned a 46 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 28-MAR-2021, the subject experienced urinary tract infection. On 28-MAR-2021, the subject experienced blood pressure so high felt like body was going to explode. Laboratory data included: Blood in urine (NR: not provided) BLOOD IN URINE, Blood pressure (NR: not provided) High, and Protein urine present (NR: not provided) PROTEIN IN URINE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the urinary tract infection and blood pressure so high felt like body was going to explode was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 46.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Chromaturia, Eye pain, Headache, Somnolence, Vision blurred
Clinical narrative: URINARY TRACT INFECTION; BLOOD PRESSURE SO HIGH FELT LIKE BODY WAS GOING TO EXPLODE; This spontaneous report received from a patient concerned a 46 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 28-MAR-2021, the subject experienced urinary tract infection. On 28-MAR-2021, the subject experienced blood pressure so high felt like body was going to explode. Laboratory data included: Blood in urine (NR: not provided) BLOOD IN URINE, Blood pressure (NR: not provided) High, and Protein urine present (NR: not provided) PROTEIN IN URINE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the urinary tract infection and blood pressure so high felt like body was going to explode was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 46.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Blood urine present, Protein urine present, Urinary tract infection
Clinical narrative: URINARY TRACT INFECTION; BLOOD PRESSURE SO HIGH FELT LIKE BODY WAS GOING TO EXPLODE; This spontaneous report received from a patient concerned a 46 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 28-MAR-2021, the subject experienced urinary tract infection. On 28-MAR-2021, the subject experienced blood pressure so high felt like body was going to explode. Laboratory data included: Blood in urine (NR: not provided) BLOOD IN URINE, Blood pressure (NR: not provided) High, and Protein urine present (NR: not provided) PROTEIN IN URINE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the urinary tract infection and blood pressure so high felt like body was going to explode was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Hyperaesthesia, Pruritus, Pyrexia, Rash
Clinical narrative: ITCHING; RASH ALL OVER BODY; CHILLS; HIVE; FATIGUE; This spontaneous report received from a patient concerned a 67 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced itching. On 02-APR-2021, the subject experienced rash all over body. On 02-APR-2021, the subject experienced chills. On 02-APR-2021, the subject experienced hive. On 02-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching, hive, rash all over body, fatigue, and chills. This report was non-serious.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: ITCHING; RASH ALL OVER BODY; CHILLS; HIVE; FATIGUE; This spontaneous report received from a patient concerned a 67 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced itching. On 02-APR-2021, the subject experienced rash all over body. On 02-APR-2021, the subject experienced chills. On 02-APR-2021, the subject experienced hive. On 02-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching, hive, rash all over body, fatigue, and chills. This report was non-serious.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Pruritus, Rash, Urticaria
Clinical narrative: ITCHING; RASH ALL OVER BODY; CHILLS; HIVE; FATIGUE; This spontaneous report received from a patient concerned a 67 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 02-APR-2021, the subject experienced itching. On 02-APR-2021, the subject experienced rash all over body. On 02-APR-2021, the subject experienced chills. On 02-APR-2021, the subject experienced hive. On 02-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itching, hive, rash all over body, fatigue, and chills. This report was non-serious.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Henoch-Schonlein purpura, Laboratory test
Clinical narrative: HENOCH-SCHONLEIN PURPURA (PURPURIC RASH ON HIS LOWER TORSO BOTH FEET AND THIGHS FRONT AND BACK, A SMALL AMOUNT ON STOMACH AROUND NAVEL AREA,'SWOLLEN FEET, KNEE SWELLING, REDNESS OF LEGS AND BRUISING UNDER THE SKIN)); This spontaneous report received from a patient concerned a retired 62 year old. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 15:00 for prophylactic vaccination on left arm. No concomitant medications were reported. On 01-APR-2021 15:30, the patient experienced henoch-schonlein purpura (purpuric rash on his lower torso both feet and thighs front and back, a small amount on stomach around navel area, swollen feet, knee swelling, redness of legs and bruising under the skin). the patient stated that rash was non-blistering, non-raised, but looks and feels like a sunburn with redness and underlying bruising. The patient went to the ER at where they gave him IV steroids and pepcid and two other medicines. The hospital discharged him the same day. On 02-Apr-2021, patient received another shot of steroid. On 05-Apr-2021, the patient visited hospital where he got diagnosed with henoch-schonlein purpura. It was stated that his actual PCP and doctor said the capillaries inside have burst causing bleeding, redness, and bruising under the skin. He states no other changes were made. Currently the rash was still present, consumer states that it looked a little lighter and a little better on the front side but on the back side it looks the same. He states the bruising seems to be getting more solid versus being spotty and that his feet and backside of his knees were swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from experienced henoch-schonlein purpura (purpuric rash on his lower torso both feet, thighs front and back, a small amount on stomach around navel area, swollen feet, knee swelling, redness of legs and bruising under the skin). This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210410644 - covid-19 vaccine ad26.cov2.s - Henoch-schonlein purpura. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Henoch-Schonlein purpura
Clinical narrative: HENOCH-SCHONLEIN PURPURA (PURPURIC RASH ON HIS LOWER TORSO BOTH FEET AND THIGHS FRONT AND BACK, A SMALL AMOUNT ON STOMACH AROUND NAVEL AREA,'SWOLLEN FEET, KNEE SWELLING, REDNESS OF LEGS AND BRUISING UNDER THE SKIN)); This spontaneous report received from a patient concerned a retired 62 year old. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 15:00 for prophylactic vaccination on left arm. No concomitant medications were reported. On 01-APR-2021 15:30, the patient experienced henoch-schonlein purpura (purpuric rash on his lower torso both feet and thighs front and back, a small amount on stomach around navel area, swollen feet, knee swelling, redness of legs and bruising under the skin). the patient stated that rash was non-blistering, non-raised, but looks and feels like a sunburn with redness and underlying bruising. The patient went to the ER at where they gave him IV steroids and pepcid and two other medicines. The hospital discharged him the same day. On 02-Apr-2021, patient received another shot of steroid. On 05-Apr-2021, the patient visited hospital where he got diagnosed with henoch-schonlein purpura. It was stated that his actual PCP and doctor said the capillaries inside have burst causing bleeding, redness, and bruising under the skin. He states no other changes were made. Currently the rash was still present, consumer states that it looked a little lighter and a little better on the front side but on the back side it looks the same. He states the bruising seems to be getting more solid versus being spotty and that his feet and backside of his knees were swollen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from experienced henoch-schonlein purpura (purpuric rash on his lower torso both feet, thighs front and back, a small amount on stomach around navel area, swollen feet, knee swelling, redness of legs and bruising under the skin). This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210410644 - covid-19 vaccine ad26.cov2.s - Henoch-schonlein purpura. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Arthralgia, Burning sensation, Catheterisation cardiac normal, Chest pain, Dyspnoea
Clinical narrative: PRESSURE IN CHEST; SHORTNESS OF BREATH; BODY ACHES; PAIN IN NECK; PAIN IN BOTH ARMS; FEVER; HEADACHE; This spontaneous report received from a parent concerned a 19 year old male. The patient's weight was 185 pounds, and height was not reported. The patient's past medical history included allergy to shell fish, and concurrent conditions included sulfa allergy, peanut allergy, tree nut allergy, allergy to coconut, allergy to peas, allergy to legumes, abstain from alcohol, and non-smoker, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced pressure in chest. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced pain in neck. On APR-2021, the subject experienced pain in both arms. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. Laboratory data included: Fever (NR: not provided) 100.5. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, pressure in chest, shortness of breath, pain in both arms, headache, body aches, and pain in neck. This report was non-serious.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Echocardiogram abnormal, Malaise, Myocardial necrosis marker increased, Neck pain, Pain in extremity
Clinical narrative: PRESSURE IN CHEST; SHORTNESS OF BREATH; BODY ACHES; PAIN IN NECK; PAIN IN BOTH ARMS; FEVER; HEADACHE; This spontaneous report received from a parent concerned a 19 year old male. The patient's weight was 185 pounds, and height was not reported. The patient's past medical history included allergy to shell fish, and concurrent conditions included sulfa allergy, peanut allergy, tree nut allergy, allergy to coconut, allergy to peas, allergy to legumes, abstain from alcohol, and non-smoker, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced pressure in chest. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced pain in neck. On APR-2021, the subject experienced pain in both arms. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. Laboratory data included: Fever (NR: not provided) 100.5. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, pressure in chest, shortness of breath, pain in both arms, headache, body aches, and pain in neck. This report was non-serious.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pericarditis, Pyrexia, Somnolence
Clinical narrative: PRESSURE IN CHEST; SHORTNESS OF BREATH; BODY ACHES; PAIN IN NECK; PAIN IN BOTH ARMS; FEVER; HEADACHE; This spontaneous report received from a parent concerned a 19 year old male. The patient's weight was 185 pounds, and height was not reported. The patient's past medical history included allergy to shell fish, and concurrent conditions included sulfa allergy, peanut allergy, tree nut allergy, allergy to coconut, allergy to peas, allergy to legumes, abstain from alcohol, and non-smoker, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced pressure in chest. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced pain in neck. On APR-2021, the subject experienced pain in both arms. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. Laboratory data included: Fever (NR: not provided) 100.5. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, pressure in chest, shortness of breath, pain in both arms, headache, body aches, and pain in neck. This report was non-serious.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Body temperature increased, Catheterisation cardiac normal, Chest pain, Chills, Dyspnoea
Clinical narrative: PRESSURE IN CHEST; SHORTNESS OF BREATH; BODY ACHES; PAIN IN NECK; PAIN IN BOTH ARMS; FEVER; HEADACHE; This spontaneous report received from a parent concerned a 19 year old male. The patient's weight was 185 pounds, and height was not reported. The patient's past medical history included allergy to shell fish, and concurrent conditions included sulfa allergy, peanut allergy, tree nut allergy, allergy to coconut, allergy to peas, allergy to legumes, abstain from alcohol, and non-smoker, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced pressure in chest. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced body aches. On APR-2021, the subject experienced pain in neck. On APR-2021, the subject experienced pain in both arms. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced headache. Laboratory data included: Fever (NR: not provided) 100.5. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, pressure in chest, shortness of breath, pain in both arms, headache, body aches, and pain in neck. This report was non-serious.